ClinConnect ClinConnect Logo
Search / Trial NCT00181233

Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk

Launched by JOHNS HOPKINS UNIVERSITY · Sep 13, 2005

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying new imaging techniques, specifically magnetic resonance imaging (MRI) and computed tomography (CT), to better understand the risk factors for sudden cardiac death. Sudden cardiac death can happen to anyone and is becoming more common, but it’s often hard to know who is at the greatest risk. The researchers aim to find out if these imaging methods can help identify people who may be at higher risk for this serious event.

To participate in this study, individuals should be between 65 and 74 years old and have a specific heart condition where the heart's pumping ability is reduced (known as a left ventricular ejection fraction of 35% or lower). They also need to be planning to have a device called an implantable cardioverter-defibrillator (ICD) put in for protection against sudden death. However, people who have a history of sudden death or cannot undergo an MRI due to certain medical devices (like a pacemaker) are not eligible. Participants can expect to undergo imaging tests and will contribute to important research that could help save lives in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Left ventricular ejection fraction \<or = 35%
  • Planned implantable cardioverter-defibrillator (ICD) implantation for clinical indications (primary prevention)
  • Exclusion Criteria:
  • History of sudden death (secondary prevention)
  • Contraindication to undergoing MRI (metallic implant, pacemaker, etc.)

About Johns Hopkins University

Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.

Locations

Baltimore, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Katherine C Wu, MD

Principal Investigator

Johns Hopkins University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials